logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Timothy Iveson

University of Southampton
H指数:52
被引数:3.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy Post Hoc Analysis of the SCOT Randomized Clinical Trial

从结直肠癌手术到辅助化疗的时间SCOT随机临床试验的事后分析

JAMA SURGERY
IF14.9
2024-08-011
PRE
Gogenur, Mikail; Rosen, Andreas Weinberger; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Tabernero, Josep; Haydon, Andrew; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; Pearson, Sarah; Boyd, Kathleen A.; Briggs, Andrew H.; Waterston, Ashita; Medley, Louise; Ellis, Richard; Dhadda, Amandeep S.; Harrison, Mark; Falk, Stephen; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Cunningham, David; Hickish, Tamas; Gollins, Simon; Wasan, Harpreet S.; Kelly, Caroline; Goegenur, Ismail; Hollaender, Niels Henrik
Single cell AI-based detection of DNA mismatch repair deficiency in 1,988 colorectal cancers reveals prognostic and predictive value in the SCOT trial

基于单细胞AI的1,988结直肠癌DNA错配修复缺陷检测揭示了SCOT试验的预后和预测价值

ANNALS OF ONCOLOGY
IF65.4
2023-10-011
PRE
Jabbar, F.; Nowak, M.; Rodewald, A-K.; Gneo, L.; Tomasevic, T.; Harkin, A.; Iveson, T. J.; Saunders, M. P.; Kerr, R.; Oien, K. A.; Maka, N.; Hay, J.; Edwards, J.; Tomlinson, I.; Sansom, O. J.; Kelly, C.; Easton, A.; Domingo, E.; Koelzer, V. H.; Church, D. N.
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

密码子特异性KRAS突变预测转移性结直肠癌中三氟尿苷/替匹拉西的生存益处

NATURE MEDICINE
IF50
2023-03-0244
OAAI
van de Haar, Joris; Ma, Xuhui; Ooft, Salo N.; van der Helm, Pim W.; Hoes, Louisa R.; Mainardi, Sara; Pinato, David J.; Sun, Kristi; Salvatore, Lisa; Tortora, Giampaolo; Zurlo, Ina Valeria; Leo, Silvana; Giampieri, Riccardo; Berardi, Rossana; Gelsomino, Fabio; Merz, Valeria; Mazzuca, Federica; Antonuzzo, Lorenzo; Rosati, Gerardo; Stavraka, Chara; Ross, Paul; Rodriquenz, Maria Grazia; Pavarana, Michele; Messina, Carlo; Iveson, Timothy; Zoratto, Federica; Thomas, Anne; Fenocchio, Elisabetta; Ratti, Margherita; Depetris, Ilaria; Cergnul, Massimiliano; Morelli, Cristina; Libertini, Michela; Parisi, Alessandro; De Tursi, Michele; Zanaletti, Nicoletta; Garrone, Ornella; Graham, Janet; Longarini, Raffaella; Gobba, Stefania Maria; Petrillo, Angelica; Tamburini, Emiliano; La Verde, Nicla; Petrelli, Fausto; Ricci, Vincenzo; Wessels, Lodewyk F. A.; Ghidini, Michele; Cortellini, Alessio; Voest, Emile E.; Valeri, Nicola
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors
CLINICAL COLORECTAL CANCER
IF3.2
2021-12-0114
OAAI
Stavraka, Chara; Pouptsis, Athanasios; Synowiec, Alicja; Angelis, Vasileios; Satterthwaite, Liyana; Khan, Sam; Chauhan, Meera; Holden, Chloe; Young, Sally; Karampera, Christina; Martinou, Maria; Mills-Baldock, Tina; Baxter, Mark; Barry, Ainsley; Eccles, Bryony; Iveson, Timothy; Shiu, Kai-Keen; Hill, Mark; Abdel-Raouf, Sherif; Graham, Janet Shirley; Thomas, Anne; Ross, Paul J.
Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative
EUROPEAN JOURNAL OF CANCER
IF7.1
2020-05-0122
OAAI
Cohen, Romain; Vernerey, Dewi; Bellera, Carine; Meurisse, Aurelia; Henriques, Julie; Paoletti, Xavier; Rousseau, Benoit; Alberts, Steven; Aparicio, Thomas; Boukovinas, Ioannis; Gill, Sharlene; Goldberg, Richard M.; Grothey, Axel; Hamaguchi, Tetsuya; Iveson, Timothy; Kerr, Rachel; Labianca, Roberto; Lonardi, Sara; Meyerhardt, Jeffrey; Paul, James; Punt, Cornelis J. A.; Saltz, Leonard; Saunders, Marck P.; Schmoll, Hans-Joachim; Shah, Manish; Sobrero, Alberto; Souglakos, Ioannis; Taieb, Julien; Takashima, Atsuo; Wagner, Anna Dorothea; Ychou, Marc; Bonnetain, Franck; Gourgou, Sophie; Yoshino, Takayuki; Yothers, Greg; de Gramont, Aimery; Shi, Qian; Andre, Thierry
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT
HEALTH TECHNOLOGY ASSESSMENT
IF4
2019-12-0126
OA
Ivesono, Timothy; Boydo, Kathleen A.; Kerro, Rachel S.; Robles-Zuritao, Jose; Saunders, Mark P.; Briggso, Andrew H.; Cassidyo, Jim; Hollandero, Niels Henrik; Taberneroo, Josep; Haydon, Andrew; Glimeliuso, Bengt; Harkino, Andrea; Allano, Karen; McQueeno, John; Pearsono, Sarah; Waterstono, Ashita; Medleyo, Louise; Wilsono, Charles; Elliso, Richard; Essapen, Sharadah; Dhaddao, Amandeep S.; Harrison, Mark; Falko, Stephen; Raoufo, Sherif; Rees, Charlotte; Oleseno, Rene K.; Proppero, David; Bridgewatero, John; Azzabio, Ashraf; Farrugiao, David; Webbo, Andrew; Cunninghamo, David; Hickish, Tamas; Weavero, Andrew; Gollins, Simon; Wasano, Harpreet; Paulo, James
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
LANCET GASTROENTEROLOGY & HEPATOLOGY
IF38.6
2019-11-0156
OAAI
Joharatnam-Hogan, Nalinie; Cafferty, Fay; Hubner, Richard; Swinson, Daniel; Sothi, Sharmila; Gupta, Kamalnayan; Falk, Stephen; Patel, Kinnari; Warner, Nicola; Kunene, Victoria; Rowley, Sam; Khabra, Komel; Underwood, Tim; Jankowski, Janusz; Bridgewater, John; Crossley, Anne; Henson, Verity; Berkman, Lindy; Gilbert, Duncan; Kynaston, Howard; Ring, Alistair; Cameron, David; Din, Farhat; Graham, Janet; Iveson, Timothy; Adams, Richard; Thomas, Anne; Wilson, Richard; Pramesh, C. S.; Langley, Ruth
Pattern Recognition Receptor Polymorphisms as Predictors of Oxaliplatin Benefit in Colorectal Cancer
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
IF7.2
2019-01-149
OAAI
Gray, Victoria; Briggs, Sarah; Palles, Claire; Jaeger, Emma; Iveson, Timothy; Kerr, Rachel; Saunders, Mark P.; Paul, James; Harkin, Andrea; McQueen, John; Summers, Matthew G.; Johnstone, Elaine; Wang, Haitao; Gatcombe, Laura; Maughan, Timothy S.; Kaplan, Richard; Escott-Price, Valentina; Al-Tassan, Nada A.; Meyer, Brian F.; Wakil, Salma M.; Houlston, Richard S.; Cheadle, Jeremy P.; Tomlinson, Ian; Church, David N.
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer

SCOT：一项大型随机对照III期试验中，两种不同疗程辅助奥沙利铂联合化疗治疗结直肠癌的成本效益比较

BRITISH JOURNAL OF CANCER
IF6.8
2018-11-1318
OAAI
Robles-Zurita, Jose; Boyd, Kathleen A.; Briggs, Andrew H.; Iveson, Timothy; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim; Hollander, Niels Henrik; Tabernero, Josep; Segelov, Eva; Glimelius, Bengt; Harkin, Andrea; Allan, Karen; McQueen, John; Pearson, Sarah; Waterston, Ashita; Medley, Louise; Wilson, Charles; Ellis, Richard; Essapen, Sharadah; Dhadda, Amandeep S.; Hughes, Rob; Falk, Stephen; Raouf, Sherif; Rees, Charlotte; Olesen, Rene K.; Propper, David; Bridgewater, John; Azzabi, Ashraf; Farrugia, David; Webb, Andrew; Cunningham, David; Hickish, Tamas; Weaver, Andrew; Gollins, Simon; Wasan, Harpreet S.; Paul, James
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

III期结肠癌辅助化疗的持续时间

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2018-03-29708
OAAI
Grothey, A.; Sobrero, A. F.; Shields, A. F.; Yoshino, T.; Paul, J.; Taieb, J.; Souglakos, J.; Shi, Q.; Kerr, R.; Labianca, R.; Meyerhardt, J. A.; Vernerey, D.; Yamanaka, T.; Boukovinas, I.; Meyers, J. P.; Renfro, L. A.; Niedzwiecki, D.; Watanabe, T.; Torri, V.; Saunders, M.; Sargent, D. J.; Andre, T.; Iveson, T.

研究方向

暂未获取到该数据
D
David Cunningham
H 指数:153论文数:2,060被引数:13.0万
T
Tamas Hickish
H 指数:58论文数:284被引数:2.3万
M
Mark Saunders
H 指数:51论文数:346被引数:1.2万
A
Andrea Harkin
H 指数:17论文数:48被引数:1,560
R
Rachel Kerr
H 指数:60论文数:318被引数:1.6万
P
Paul J. Ross
H 指数:61论文数:397被引数:2.3万
A
A. Norman
H 指数:64论文数:261被引数:1.6万
S
Stephen Falk
H 指数:57论文数:220被引数:2.5万
C
Caroline Kelly
H 指数:22论文数:109被引数:1,575
M
Mark Hill
H 指数:44论文数:154被引数:8,092